| Synonyms | | Synonym | Source |
|---|
| (5Z,8Z,11Z,14Z)-5,8,11,14-Icosatetraenoic acid | ChEBI | | (5Z,8Z,11Z,14Z)-Icosatetraenoic acid | ChEBI | | AA | ChEBI | | all-cis-5,8,11,14-Eicosatetraenoic acid | ChEBI | | ARA | ChEBI | | Arachidonate | ChEBI | | Arachidonsaeure | ChEBI | | cis-5,8,11,14-Eicosatetraenoic acid | ChEBI | | cis-Delta(5,8,11,14)-Eicosatetraenoic acid | ChEBI | | 5Z,8Z,11Z,14Z-Eicosatetraenoic acid | Kegg | | (5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid | Kegg | | (5Z,8Z,11Z,14Z)-5,8,11,14-Icosatetraenoate | Generator | | (5Z,8Z,11Z,14Z)-Icosatetraenoate | Generator | | all-cis-5,8,11,14-Eicosatetraenoate | Generator | | cis-5,8,11,14-Eicosatetraenoate | Generator | | cis-delta(5,8,11,14)-Eicosatetraenoate | Generator | | cis-Δ(5,8,11,14)-eicosatetraenoate | Generator | | cis-Δ(5,8,11,14)-eicosatetraenoic acid | Generator | | 5Z,8Z,11Z,14Z-Eicosatetraenoate | Generator | | (5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoate | Generator | | Arachidonic acid, (all-Z)-isomer, 1-(14)C-labeled | MeSH | | Arachidonic acid, zinc salt, (all-Z)-isomer | MeSH | | Sodium arachidonate | MeSH | | Arachidonate, sodium | MeSH | | Arachidonic acid, (all-Z)-isomer, 3H-labeled | MeSH | | Arachidonic acid, ammonium salt, (all-Z)-isomer | MeSH | | Arachidonic acid, cerium salt, (all-Z)-isomer | MeSH | | Arachidonic acid, sodium salt | MeSH | | Arachidonic acid, sodium salt, (all-Z)-isomer | MeSH | | Vitamin F | MeSH | | Arachidonic acid, cesium salt, (all-Z)-isomer | MeSH | | Arachidonic acid, lithium salt, (all-Z)-isomer | MeSH | | (all-Z)-5,8,11,14-Eicosatetraenoic acid | MeSH | | Arachidonic acid, potassium salt, (all-Z)-isomer | MeSH | | (all-Z)-5,8,11,14-Eicosatetraenoate | HMDB | | 5,8,11,14-all-cis-Eicosatetraenoate | HMDB | | 5,8,11,14-all-cis-Eicosatetraenoic acid | HMDB | | 5,8,11,14-Eicosatetraenoate | HMDB | | 5,8,11,14-Eicosatetraenoic acid | HMDB | | 5-cis,8-cis,11-cis,14-cis-Eicosatetraenoate | HMDB | | 5-cis,8-cis,11-cis,14-cis-Eicosatetraenoic acid | HMDB | | cis-D5,8,11,14-Eicosatetraenoate | HMDB | | cis-D5,8,11,14-Eicosatetraenoic acid | HMDB | | Immunocytophyte | HMDB | | FA(20:4(5Z,8Z,11Z,14Z)) | HMDB | | FA(20:4n6) | HMDB | | 5,8,11,14-Eicosatetraenoic acid, (all-Z)- | biospider | | Arachidonic acid | db_source | | cis-5,8,11,14-eicosatetraenoic acid | biospider | | cis-delta-5,8,11,14-eicosatetraenoic acid | manual | | cis-δ(5,8,11,14)-eicosatetraenoate | Generator | | cis-δ(5,8,11,14)-eicosatetraenoic acid | Generator |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative | splash10-0nmi-0913000000-95846e8d5e8afd29664b | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-005l-0902100000-6fc8730bd28daa779b66 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-005l-0902100000-6fc8730bd28daa779b66 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF , Negative | splash10-005l-0902100000-6fc8730bd28daa779b66 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0udi-0009000000-4dd23c77f8e48c0ab9ec | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 30V, Negative | splash10-0udi-0009000000-4dd23c77f8e48c0ab9ec | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0udi-0009000000-6bd9d0477c122d3eed94 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-0udi-0009000000-510ea33e558fa238a1d2 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF , Negative | splash10-0udi-0009000000-73a6b21464acba15463c | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0udi-0009000000-4dd23c77f8e48c0ab9ec | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 30V, Negative | splash10-0udi-0049000000-102d050109d3c78b1a25 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-IT , negative | splash10-0a4i-0090000000-2fb9003e782ec3d05e20 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , negative | splash10-0nmi-0913000000-95846e8d5e8afd29664b | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-0udi-0009000000-6bd9d0477c122d3eed94 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-0udi-0009000000-510ea33e558fa238a1d2 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-0udi-0049000000-102d050109d3c78b1a25 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-0009000000-6bd9d0477c122d3eed94 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-0udi-0009000000-510ea33e558fa238a1d2 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 6V, Positive | splash10-0a4i-1934000000-3fb5938d1b4795217a97 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a4r-1196000000-a42ea66033eb9771d36d | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4j-5691000000-2bc7b1ae5487233dfce8 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0007-7950000000-b15a8d382a4b3ad62d08 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0029000000-28a9bbfed5fabd10c0c2 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0zfr-2079000000-3f6e64ef7522a793e9a9 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-9130000000-9c0c8bb5fc8e30bf53c7 | 2017-07-26 | View Spectrum |
|
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| 5-alpha-reductase inhibitor | 50781 | An agent that blocks the conversion of testosterone to dihydrotestosterone, reducing androgenic effects. Therapeutically, it treats benign prostatic hyperplasia, androgenetic alopecia, and acne, by decreasing prostate size, promoting hair growth, and minimizing sebaceous gland activity. | DUKE | | Anti dermatitic | 50177 | An agent that reduces skin inflammation and irritation, commonly used to treat dermatitis, eczema, and other skin disorders, providing relief from itching, redness, and swelling. | DUKE | | Anti eczemic | 52217 | An agent that reduces inflammation and itching, commonly used to manage eczema symptoms, atopic dermatitis, and other skin allergies, providing relief and preventing flare-ups. | DUKE | | Anti leukotriene-B4 | 35222 | An agent that inhibits leukotriene B4, reducing inflammation and immune responses. It has therapeutic applications in managing inflammatory diseases, such as asthma and arthritis, by blocking leukotriene B4's role in attracting white blood cells to sites of inflammation. Key medical uses include treating respiratory and autoimmune disorders. | DUKE | | Anti-psoriatic | 52217 | An agent that reduces psoriasis symptoms, commonly used in managing plaque psoriasis, scalp psoriasis, and other inflammatory skin conditions, by modulating the immune system and inhibiting keratinocyte proliferation. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Coagulant | | An agent that causes blood or another liquid to coagulate, playing a crucial biological role in wound healing and hemostasis. Therapeutically, coagulants are used to treat bleeding disorders, such as hemophilia, and to prevent excessive bleeding during surgery, with key medical uses including trauma treatment and transfusion medicine. | DUKE | | Hepatoprotective | 62868 | An agent that protects the liver from damage, promoting liver health and function. It plays a biological role in reducing oxidative stress and inflammation, and has therapeutic applications in managing liver diseases, such as hepatitis and cirrhosis, and key medical uses in treating drug-induced liver injury and toxicities. | DUKE | | Immunostimulant | 50847 | An agent that stimulates the immune system, enhancing its response to infections and diseases. Therapeutically, it boosts the body's natural defenses, commonly used to treat immunodeficiency disorders, prevent infections, and support cancer treatment, as well as manage chronic conditions like hepatitis and HIV. | DUKE | | Insulinogenic | | An agent that stimulates insulin production and release by the pancreas, used therapeutically to manage diabetes and impaired glucose tolerance, and medically to treat conditions like hypoglycemia and insulin resistance. | DUKE | | Myocontractant | | An agent that stimulates contractions of smooth muscle, playing a biological role in regulating muscle tone. Therapeutically, it has applications in treating conditions like uterine atony and gastrointestinal disorders. Key medical uses include inducing labor, managing postpartum hemorrhage, and treating gastrointestinal motility issues. | DUKE | | Pyrogenic | | An agent that induces fever, stimulating the immune system. It plays a biological role in fighting infection and has therapeutic applications in immunotherapy and vaccine development. Key medical uses include treating certain infections and cancers, as well as stimulating the immune system in immunocompromised patients. | DUKE |
|
|---|